Kidney development and gene expression in the HIF2α knockout mouse

Developmental Dynamics

Volumn 236, Issue 4, 2007, Pages 1115-1125

  Steenhard, Brooke M ^a   Freeburg, Paul B ^a   Isom, Kathryn ^a   Stroganova, Larysa ^a   Borza, Dorin Bogdan ^b   Hudson, Billy G ^b   St John, Patricia L ^a   Zelenchuk, Adrian ^a   Abrahamson, Dale R ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Flk 1; Glomerulus; HIF; Hypoxia; VEGF

Indexed keywords

BETA GALACTOSIDASE; CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MUTANT PROTEIN; PROTEIN; PROTEIN BSLB4; PROTEIN GLEPP1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; WT1 PROTEIN;

ANIMAL TISSUE; ARTICLE; ELECTRON MICROSCOPY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HYPOXIA; KIDNEY DEVELOPMENT; KNOCKOUT MOUSE; MESANGIUM CELL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIBLING; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY; KIDNEY TRANSPLANTATION; LAC OPERON; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS MUSCULUS;

EID: 34247340597     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21106     Document Type: Article

References (48)

1. Abrahamson DR, St. John PL. 1992. Loss of laminin epitopes during glomerular basement membrane assembly in developing mouse kidneys. J Histochem Cytochem 40:1943-1953.
2. Bernhardt WM, Schmitt R, Rosenberger C, Munchenhagen PM, Grone HJ, Frei U, Warnecke C, Bachman S, Wiesener MS, Willam C, Eckardt KU. 2006. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int 69:114-122.
3. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P. 2002. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8:702-710.
4. Crews ST. 1998. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev 12:607-620.
5. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, Flamme I. 2003. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278:7520-7530.
6. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 94:4273-4278.
7. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE. 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111:707-716.
8. Ferrara N. 2001. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358-C1366.
9. Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, Risau W. 1997. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels. Mech Dev 63:51-60.
10. Freeburg PB, Robert B, St. John PL, Abrahamson DR. 2003. Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14:927-938.
11. Gerber HP, Condorelli F, Park J, Ferrara N. 1997. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272:23659-23667.
12. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. 1999. VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159.
13. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA. 1998. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7:205-213.
14. Gu YZ, Hogenesch JB, Bradfield CA. 2000. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519-561.
15. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. 2006. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214-F222.
16. Haase VH. 2006. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291:F271-F281.
17. Hara S, Hamada J, Kobayashi C, Kondo Y, Imura N. 2001. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: suppression of HIF-mediated gene expression by HIF-3alpha. Biochem Biophys Res Commun 287:808-813.
18. Heidet L, Borza DB, Jouin M, Sich M, Mattei MG, Sado Y, Hudson BG, Hastie N, Antignac C, Gubler MC. 2003. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice. Am J Pathol 163:1633-1644.
19. Hu CJ, Wang LY, Chodosh LW, Keith B, Simon MC. 2003. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23:9361-9374.
20. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468.
21. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
22. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472.
23. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. 1996. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771-17778.
24. Kappel A., Ronicke V, Damert A, Flamme I, Risau W, Breier G. 1999. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93:4284-4292.
25. Kitamoto Y, Tokunaga H, Tomita K. 1997. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Invest 99:2351-2357.
26. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. 2002. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295:858-861.
27. Levy AP, Levy NS, Wegner S, Goldberg MA. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340.
28. Liu Y, Cox SR, Morita T, Kourembanas S. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77:638-643.
29. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
30. Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez RA, Collen D, Carmeliet P. 2002. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 13:1548-1560.
31. Maxwell PH, Ratcliffe PJ. 2002. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13:29-37.
32. O'Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW. 1999. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J Biol Chem 274:2060-2071.
33. Park SK, Dadak AM, Haase VH, Fontana L, Giaccia AJ, Johnson RS. 2003. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 23:4959-4971.
34. Peng J, Zhang L, Drysdale L, Fong GH. 2000. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 97:8386-8391.
35. Robert B, Abrahamson DR. 2001. Control of glomerular capillary development by growth factor/receptor kinases. Pediatr Nephrol 16:294-301.
36. Robert B, St. John PL, Abrahamson DR. 1998. Direct visualization of renal vascular morphogenesis in Flk1 heterozygous mutant mice. Am J Physiol 275:F164-F172.
37. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU. 2002. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13:1721-1732.
38. Rossant J, Howard L. 2002. Signaling pathways in vascular development. Annu Rev Cell Dev Biol 18:541-573.
39. Ryan HE, Lo J, Johnson RS. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005-3015.
40. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, Marck BT, Matsumoto AM, Shelton JM, Richardson JA, Bennett MJ, Garcia JA. 2003a. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 35:331-340.
41. Scortegagna M, Morris MA, Oktay Y, Bennett M, Garcia JA. 2003b. The HIF family member EPAS1/HIF-2alpha is required for normal hematopoiesis in mice. Blood 102:1634-1640.
42. Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, Ali IU, Smith LE, Senger DR. 2002. Molecular profiling of angiogenesis markers. Am J Pathol 161:35-41.
43. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E. 1995. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250.
44. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. 2003. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria, J Biol Chem 278:12605-12608.
45. Tian H, McKnight SL, Russell DW. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72-82.
46. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. 1998. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12:3320-3324.
47. Wang GL, Semenza GL. 1995. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237.
48. Wang R, St. John PL, Kretzler M, Wiggins RC, Abrahamson DR. 2000. Molecular cloning, expression, and distribution of glomerular epithelial protein 1 in developing mouse kidney. Kidney Int 57:1847-1859.